Drug Information Association, Beijing China
May 16 2010 - May 19 2010
China’s drug innovation and development are moving ahead rapidly. A local, as well as global, perspective will help all players involved to exchange critical information for research and strategic positioning in an increasingly complex regulatory landscape. This second DIA China Annual Meeting will serve as an international, neutral forum to discuss priming China as a leader in executing drug development. Speakers from major regulatory agencies, industry, and academia will present and lead the panels and sessions. This multidisciplinary meeting will benefi t all professionals from regulatory agencies and institutions, the biopharmaceutical industry, investigational sites, contract research organizations, and academia. Together we can better understand how to reach the next stage for our profession as well as deliver benefi ts for human health and well-being globally.
|
|